Bortesi Luisa, Rossato Marzia, Schuster Flora, Raven Nicole, Stadlmann Johannes, Avesani Linda, Falorni Alberto, Bazzoni Flavia, Bock Ralph, Schillberg Stefan, Pezzotti Mario
Scientific and Technologic Department, University of Verona, Strada Le Grazie 15, Verona, Italy.
BMC Biotechnol. 2009 Mar 19;9:22. doi: 10.1186/1472-6750-9-22.
Interleukin-10 (IL-10) is a potent anti-inflammatory cytokine, with therapeutic applications in several autoimmune and inflammatory diseases. Oral administration of this cytokine alone, or in combination with disease-associated autoantigens could confer protection form the onset of a specific autoimmune disease through the induction of oral tolerance. Transgenic plants are attractive systems for production of therapeutic proteins because of the ability to do large scale-up at low cost, and the low maintenance requirements. They are highly amenable to oral administration and could become effective delivery systems without extensive protein purification. We investigated the ability of tobacco plants to produce high levels of biologically-active viral and murine IL-10.
Three different subcellular targeting strategies were assessed in transient expression experiments, and stable transgenic tobacco plants were generated with the constructs that yielded the highest accumulation levels by targeting the recombinant proteins to the endoplasmic reticulum. The best yields using this strategy in T1 plants were 10.8 and 37.0 microg/g fresh leaf weight for viral and murine IL-10, respectively. The recombinant proteins were purified from transgenic leaf material and characterized in terms of their N-glycan composition, dimerization and biological activity in in vitro assays. Both molecules formed stable dimers, were able to activate the IL-10 signaling pathway and to induce specific anti-inflammatory responses in mouse J774 macrophage cells.
Tobacco plants are able to correctly process viral and murine IL-10 into biologically active dimers, therefore representing a suitable platform for the production for these cytokines. The accumulation levels obtained are high enough to allow delivery of an immunologically relevant dose of IL-10 in a reasonable amount of leaf material, without extensive purification. This study paves the way to performing feeding studies in mouse models of autoimmune diseases, that will allow the evaluation the immunomodulatory properties and effectiveness of the viral IL-10 in inducing oral tolerance compared to the murine protein.
白细胞介素-10(IL-10)是一种强效抗炎细胞因子,在多种自身免疫性疾病和炎症性疾病中具有治疗应用。单独口服这种细胞因子,或与疾病相关自身抗原联合使用,可通过诱导口服耐受来预防特定自身免疫性疾病的发生。转基因植物是生产治疗性蛋白质的有吸引力的系统,因为它们能够低成本大规模扩大生产,且维护要求低。它们非常适合口服给药,无需大量蛋白质纯化即可成为有效的递送系统。我们研究了烟草植物产生高水平生物活性病毒和小鼠IL-10的能力。
在瞬时表达实验中评估了三种不同的亚细胞靶向策略,并通过将重组蛋白靶向内质网产生了积累水平最高的构建体,从而获得了稳定的转基因烟草植物。使用该策略在T1植物中获得的最佳产量分别为病毒IL-10和小鼠IL-10每克鲜叶重各10.8微克和37.0微克。从转基因叶片材料中纯化重组蛋白,并在体外测定中对其N-聚糖组成、二聚化和生物活性进行了表征。两种分子均形成稳定的二聚体,能够激活IL-10信号通路并在小鼠J774巨噬细胞中诱导特异性抗炎反应。
烟草植物能够将病毒和小鼠IL-10正确加工成具有生物活性的二聚体,因此是生产这些细胞因子的合适平台。获得的积累水平足够高,能够在合理数量的叶片材料中递送免疫相关剂量的IL-10,而无需大量纯化。本研究为在自身免疫性疾病小鼠模型中进行喂养研究铺平了道路,这将有助于评估病毒IL-10与小鼠蛋白相比在诱导口服耐受方面的免疫调节特性和有效性。